Resources Contact Us Home
Clostridium perfringens alpha toxin proteins

Image Number 6 for United States Patent #7982006.

This invention pertains in part to the development of a vaccine for poultry against necrotic enteritis (NE). The vaccine utilizes a protective antigen that is a mutated, full-length, non-toxic Clostridium perfringens (Cp) .alpha.-toxin protein (Mcpa). Utility of this vaccine was demonstrated by reduction of lesion severity in NE challenge trails, for example. Also disclosed herein are novel approaches for producing this vaccine in significant quantities. One exemplified approach involves producing NE vaccine (mutated alpha toxin) in bacterial expression systems, preferably utilizing the Pseudomonas fluorescens system, for commercial use in controlling NE in the poultry industry. The subject vaccines can be administered preferably to chickens in several different ways. A novel, Type VI alpha toxin from chicken isolates of Cp is also disclosed.

  Recently Added Patents
Optical receiver and optical transfer apparatus
Method for configuring analog-to-digital converter keys and non-transitory machine readable medium storing program code executed for performing such method
High performance actuator motor
Method and system for using personal devices for authentication and service access at service outlets
Header rail for a shower screen or the like
System and method for deposition in high aspect ratio magnetic writer heads
Vehicle, toy, and/or replicas thereof
  Randomly Featured Patents
Band applicator for appendicular and meso-appendicular stumps
Faucet handle
Private messaging a second recipient of an electronic communication
Shredding machine
Access valve devices, their use in separation apparatus and corresponding methods
8T low leakage SRAM cell
Graphical user interface widgets viewable and readable from multiple viewpoints in a volumetric display
Inherently ink-receptive film substrates
Preparation of 5-aroyl-pyrrole compounds
Piperidine derivatives and their use as modulators of chemokine receptor activity (especially CCR5)